product summary
Loading...
company name :
Bio-Rad
other brands :
Biogenesis, Serotec, AbD Serotec, Oxford Biotechnology
product type :
antibody
product name :
Mouse anti Feline Calicivirus
catalog :
MCA1887
quantity :
0.25 mg
price :
411 USD
clonality :
monoclonal
host :
mouse
conjugate :
nonconjugated
clone name :
FCV1-43
application :
western blot, ELISA
more info or order :
product information
Entity Type :
Monoclonal Antibody
Entity Category :
Antibodies
ProductCode :
MCA1887
Description :
Mouse anti Feline Calicivirus
Specificity :
Calicivirus
TargetSpecies :
Viral
Host :
Mouse
Format :
Purified
Isotypes :
IgG2a
Applications :
WB,P,E
ApplicationTypes :
Western Blotting,Immunohistology - Paraffin,ELISA
Clone :
FCV1-43
Quantity :
0.25 mg
Quantity Value :
0.25
Quantity Type :
mg
Entity Formats :
Purified
UNSPSC :
41116161
Concentration :
IgG concentration 1.0 mg/ml
Product Form :
Purified IgG - liquid
PriceGBP :
294
PriceEUR :
411
PriceUSD :
411 USD
PriceCHF :
447
PriceSEK :
4480
PriceNOK :
4502
PriceDKK :
3064
NotForSaleInCountries :
AU
more info or order :
company information
Bio-Rad
Endeavour House, Langford Business Park
Langford Lane, Kidlington
OXON, OX5 1GE
antibody_sales_uk@bio-rad.com
https://www.bio-rad-antibodies.com
1 800 265 7376 (North America)
44 (0)1865 852 700 (Rest of World)
headquarters: UK
Bio-Rad is one of the world's leading antibody manufacturers, offering over 12,000 antibodies and related reagents for a focused range of research areas such as immunology, cancer, veterinary research and cell biology through its antibody experts formerly known as AbD Serotec.
The range includes apoptosis kits, autophagy reagents, CD markers, epitope tag antibodies, immunology antibodies, neuroscience antibodies, and veterinary reagents.
Bio-Rad has an ISO 9001 and ISO 13485 certified production facility in the United Kingdom as well as ISO 9001 certified facilities in Germany and the United States.
Our expertise extends to traditional and recombinant antibody generation and production services. Our custom generation service delivers antibodies in as little as 8 weeks with greater than 90% success. The in vitro technology enables selection of antibodies to challenging targets, long term consistent supply, and provision of the antibody sequence.
At Bio-Rad we are committed to your success when using our antibodies and we focus on providing the technology, products and all the supporting information you need to excel in your research.